US appeals court revives hundreds of private lawsuits linking Tylenol to autism 

 ADHD in the News 2026-07-16


NEW YORK, July 13 (Reuters) - A federal appeals court on Monday revived more than 500 private lawsuits against Tylenol maker Kenvue (KVUE.N), opens new tab over ‌the painkiller's alleged link to autism. The 2nd U.S. Circuit Court of Appeals in Manhattan said a district court judge improperly excluded expert testimony from three doctors offered by parents and guardians who tied Tylenol use during pregnancy to autism and attention deficit hyperactivity disorder (ADHD) in children.

View Article: Reuters, July 13, 2026




Other Articles in this Edition

Adderall Misuse Falls Sharply Among Young Adults, Study Finds 

US appeals court revives hundreds of private lawsuits linking Tylenol to autism 

Two Telehealth Executives Sentenced for Scheme to Distribute Adderall 

Research Highlights Concussion Challenges for Athletes with ADHD

Leading ADHD medications found to be equally effective in children, with one key difference 

Better diets are linked to sharper focus in teens with attention disorders

ADHD patients in N.J. can now refill their medications from home 

Wanted: Neurodivergent Motivation

Adults with ADHD who struggle to manage emotions face a higher insomnia risk

ADHD traits more common in runners, new research suggests 

Neurodiversity is a gift, ‘not a problem to be solved’, says the Archbishop of Canterbury 

‘Adventures of a Stupid Boy’ recounts growing up with undiagnosed ADHD 

Natalie Imbruglia Says Perimenopause Made Her ADHD, OCD Symptoms ‘Worse’: ‘I Fell Off a Cliff’